Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

AbbVie’s Skyrizi and Rinvoq were practically unshakeable atop the monthly TV drug ad spending rankings, ultimately leading ...

AZ and Regeneron will collaborate on finding small ... which puts the programme firmly in AZ's wheelhouse given its focus on diabetes with drugs like its blockbuster SGLT2 inhibitor Farxiga ...

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...

Auburn University and the I-Stem Connectory at AU hosted the 2025 Alabama Science and Engineering Fair on Saturday, April 5.

Alnylam Pharmaceuticals, Inc.’s ALNY share price has dipped by 10.08%, which has investors questioning if this is right time ...

Regeneron and GlaxoSmithKline have joined forces to generate genetic sequence data from the 500,000 volunteers in the UK’s Biobank database. The companies hope the initiative will give insights ...

General Douglas MacArthur High School in the Levittown School District has announced Melody Hong and Katherine Tian as its ...

Regeneron’s Eylea franchise remains resilient despite biosimilar competition, with Eylea HD showing strong performance and new innovations like a pre-filled syringe on the horizon. Dupixent ...

Regeneron Pharmaceuticals saw its share price decline by 10% over the past week. The recent approval of Dupixent for COPD in Japan was expected to bolster investor confidence, yet the broader ...

Antibiotic Exposure in Infancy May Boost Type 1 Diabetes Risk Mar. 25, 2025 — Exposure to antibiotics during a key developmental window in infancy can stunt growth of insulin-producing cells in ...

Regeneron Pharmaceuticals Inc REGN raises some concerns due to its significant presence in Ireland. If tariffs are applied, they would likely increase the cost of goods sold since companies often ...